AwesomeCapital: vTv $51 M Private Placement from Institutions

Wednesday, February 28, 2024

vTv $51 M Private Placement from Institutions

Proceeds to fully fund first Phase 3 study of cadisegliatin, expected to initiate in mid-2024

https://www.globenewswire.com/news-release/2024/02/28/2836891/0/en/vTv-Therapeutics-Announces-51-Million-Private-Placement-from-Healthcare-focused-Institutional-Investors-and-the-JDRF-T1D-Fund.html

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)